Camylofin, Diclofenac

Camylofin is a unique combination medication consisting of Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), and Camosate, a reversible, non-competitive inhibitor of carbonic anhydrase. This combination medication is specifically designed to provide both analgesic and anti-inflammatory effects, as well as to treat symptoms of increased intracranial pressure, such as headaches, dizziness, and nausea.
Diclofenac is widely used to relieve pain, reduce inflammation, and alleviate symptoms associated with various conditions like arthritis, muscle strains, and dental pain. As an NSAID, Diclofenac works by inhibiting the enzyme cyclooxygenase (COX), which plays a crucial role in the production of prostaglandins – chemicals responsible for inflammation and pain.
On the other hand, Camosate is used to inhibit the activity of carbonic anhydrase, an enzyme involved in the production of bicarbonate ions, which helps maintain the body’s fluid and electrolyte balance. By inhibiting carbonic anhydrase, Camosate can help regulate the amount of fluid in the eye and the surrounding tissues, providing relief from increased intracranial pressure and associated symptoms.